Literature DB >> 33481780

Individual adherence to mass drug administration in neglected tropical disease control: A probability model conditional on past behaviour.

Robert J Hardwick1,2,3, James E Truscott1,2,3, William E Oswald4, Marleen Werkman1,2,3, Katherine E Halliday4, Rachel L Pullan4, Roy M Anderson1,2,3.   

Abstract

We present a general framework which describes the systematic (binary) scenario of individuals either taking treatment or not for any reason, over the course of mass drug administration (MDA)-which we refer to as 'adherence' and 'non-adherence'. The probability models developed can be informed by observed adherence behaviour as well as employed to explore how different patterns influence the impact of MDA programmes, by the use of mathematical models of transmission and control. We demonstrate the interpretative value of the developed probability model employing a dataset collected in the TUMIKIA project, a randomised trial of deworming strategies to control soil-transmitted helminths (STH) by MDA conducted in coastal Kenya. We stratify our analysis by age and sex, although the framework which we introduce here may be readily adapted to accommodate other stratifications. Our findings include the detection of specific patterns of non-adherence in all age groups to varying extents. This is particularly apparent in men of ages 30+. We then demonstrate the use of the probability model in stochastic individual-based simulations by running two example forecasts for the elimination of STH transmission employing MDA within the TUMIKIA trial setting with different adherence patterns. This suggested a substantial reduction in the probability of elimination (between 23-43%) when comparing observed adherence patterns with an assumption of independence, with important implications for programmes. The results here demonstrate the considerable impact and utility of considering non-adherence on the success of MDA programmes to control neglected tropical diseases (NTDs).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33481780      PMCID: PMC7857569          DOI: 10.1371/journal.pntd.0009112

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  17 in total

Review 1.  Patient adherence to HIV medication regimens: a review of published and abstract reports.

Authors:  Linda Fogarty; Debra Roter; Susan Larson; Jessica Burke; Jeanne Gillespie; Richard Levy
Journal:  Patient Educ Couns       Date:  2002-02

Review 2.  Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.

Authors:  Bontha V Babu; Gopalan R Babu
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-04-11       Impact factor: 2.184

Review 3.  A research agenda for helminth diseases of humans: towards control and elimination.

Authors:  Boakye A Boatin; María-Gloria Basáñez; Roger K Prichard; Kwablah Awadzi; Rashida M Barakat; Héctor H García; Andrea Gazzinelli; Warwick N Grant; James S McCarthy; Eliézer K N'Goran; Mike Y Osei-Atweneboana; Banchob Sripa; Guo-Jing Yang; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

4.  Modelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination.

Authors:  M A Irvine; L J Reimer; S M Njenga; S Gunawardena; L Kelly-Hope; M Bockarie; T D Hollingsworth
Journal:  Parasit Vectors       Date:  2015-10-22       Impact factor: 3.876

5.  Effects, equity, and cost of school-based and community-wide treatment strategies for soil-transmitted helminths in Kenya: a cluster-randomised controlled trial.

Authors:  Rachel L Pullan; Katherine E Halliday; William E Oswald; Carlos Mcharo; Emma Beaumont; Stella Kepha; Stefan Witek-McManus; Paul M Gichuki; Elizabeth Allen; Tom Drake; Catherine Pitt; Sultani H Matendechero; Marie-Claire Gwayi-Chore; Roy M Anderson; Sammy M Njenga; Simon J Brooker; Charles S Mwandawiro
Journal:  Lancet       Date:  2019-04-18       Impact factor: 202.731

6.  Patterns of individual non-treatment during multiple rounds of mass drug administration for control of soil-transmitted helminths in the TUMIKIA trial, Kenya: a secondary longitudinal analysis.

Authors:  William E Oswald; Stella Kepha; Katherine E Halliday; Carlos Mcharo; Th'uva Safari; Stefan Witek-McManus; Robert J Hardwick; Elizabeth Allen; Sultani H Matendechero; Simon J Brooker; Sammy M Njenga; Charles S Mwandawiro; Roy M Anderson; Rachel L Pullan
Journal:  Lancet Glob Health       Date:  2020-11       Impact factor: 26.763

Review 7.  Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.

Authors:  Kathryn V Shuford; Hugo C Turner; Roy M Anderson
Journal:  Parasit Vectors       Date:  2016-01-27       Impact factor: 3.876

8.  Assessing the feasibility of interrupting the transmission of soil-transmitted helminths through mass drug administration: The DeWorm3 cluster randomized trial protocol.

Authors:  Kristjana Hrönn Ásbjörnsdóttir; Sitara S Rao Ajjampur; Roy M Anderson; Robin Bailey; Iain Gardiner; Katherine E Halliday; Moudachirou Ibikounle; Khumbo Kalua; Gagandeep Kang; D Timothy J Littlewood; Adrian J F Luty; Arianna Rubin Means; William Oswald; Rachel L Pullan; Rajiv Sarkar; Fabian Schär; Adam Szpiro; James E Truscott; Marleen Werkman; Elodie Yard; Judd L Walson
Journal:  PLoS Negl Trop Dis       Date:  2018-01-18

9.  The Geshiyaro Project: a study protocol for developing a scalable model of interventions for moving towards the interruption of the transmission of soil-transmitted helminths and schistosome infections in the Wolaita zone of Ethiopia.

Authors:  Kalkidan Mekete; Alison Ower; Julia Dunn; Heven Sime; Gemechu Tadesse; Ebba Abate; Nebiyu Nigussu; Fikreselasie Seife; Emily McNaughton; Roy Malcolm Anderson; Anna Elizabeth Phillips
Journal:  Parasit Vectors       Date:  2019-10-29       Impact factor: 3.876

10.  Heterogeneity in transmission parameters of hookworm infection within the baseline data from the TUMIKIA study in Kenya.

Authors:  James E Truscott; Alison K Ower; Marleen Werkman; Katherine Halliday; William E Oswald; Paul M Gichuki; Carlos Mcharo; Simon Brooker; Sammy M Njenga; Charles Mwandariwo; Judd L Walson; Rachel Pullan; Roy Anderson
Journal:  Parasit Vectors       Date:  2019-09-16       Impact factor: 3.876

View more
  4 in total

1.  How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases.

Authors:  Jessica Clark; Wilma A Stolk; María-Gloria Basáñez; Luc E Coffeng; Zulma M Cucunubá; Matthew A Dixon; Louise Dyson; Katie Hampson; Michael Marks; Graham F Medley; Timothy M Pollington; Joaquin M Prada; Kat S Rock; Henrik Salje; Jaspreet Toor; T Déirdre Hollingsworth
Journal:  Gates Open Res       Date:  2022-02-02

2.  Longitudinal monitoring of prevalence and intensity of soil-transmitted helminth infections as part of community-wide mass drug administration within the Geshiyaro project in the Bolosso Sore district, Wolaita, Ethiopia.

Authors:  Toby Landeryou; Rosie Maddren; Santiago Rayment Gomez; Suprabhath Kalahasti; Ewnetu Firdawek Liyew; Melkie Chernet; Hussein Mohammed; Yonas Wuletaw; James Truscott; Anna E Phillips; Alison Ower; Kathryn Forbes; Ufaysa Anjulo; Birhan Mengistu; Geremew Tasew; Mihretab Salasibew; Roy Anderson
Journal:  PLoS Negl Trop Dis       Date:  2022-09-19

3.  Impact of Key Assumptions About the Population Biology of Soil-Transmitted Helminths on the Sustainable Control of Morbidity.

Authors:  Carolin Vegvari; Federica Giardina; Veronica Malizia; Sake J de Vlas; Luc E Coffeng; Roy M Anderson
Journal:  Clin Infect Dis       Date:  2021-06-14       Impact factor: 9.079

4.  Schistosomiasis, soil transmitted helminthiasis, and malaria co-infections among women of reproductive age in rural communities of Kwale County, coastal Kenya.

Authors:  Victor Tunje Jeza; Francis Mutuku; Lydia Kaduka; Charles Mwandawiro; Janet Masaku; Collins Okoyo; Henry Kanyi; Joyce Kamau; Zipporah Ng'ang'a; Jimmy Hussein Kihara
Journal:  BMC Public Health       Date:  2022-01-19       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.